139 participants
NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-03
- Start Date:
- 2024-03-27
- Completion:
- 2034-06-30
Conditions
- Adipocytic Neoplasm
- Liposarcoma
- Atypical Fibroxanthoma
- Angiomatoid Fibrous Histiocytoma
- Fibrosarcoma NOS
- Myxofibrosarcoma
- Angiosarcoma
- Osteosarcoma, Extraskeletal
- Dedifferentiated Liposarcoma
- Myxoid Liposarcoma
- Pleomorphic Liposarcoma
- Myxoid Pleomorphic Liposarcoma
- Low Grade Fibromyxoid Sarcoma
- Sclerosing Epithelioid Fibrosarcoma
- Malignant Tenosynovial Giant Cell Tumor of Soft Tissue
- Epithelioid Hemangioendothelioma
- Glomus Tumor
- Inflammatory Leiomyosarcoma
- Leiomyosarcoma
- Ossifying Fibromyxoid Tumor, Malignant
- Myoepithelioma
- Synovial Sarcoma
- Epithelioid Sarcoma
- Perineurioma, Malignant
- Clear Cell Sarcoma
- Extraskeletal Myxoid Chondrosarcoma
- Granular Cell Tumor, Malignant
- Melanotic Malignant Nerve Sheath Tumor
- Malignant Peripheral Nerve Sheath Tumor
- Perivascular Epithelioid Tumor, Malignant
- Intimal Sarcoma
- Myoepithelial Carcinoma
- Undifferentiated Sarcoma
- Pleomorphic Sarcoma, Undifferentiated
- Round Cell Sarcoma, Undifferentiated
- NTRK-Rearranged Spindle Cell Neoplasm
- Phosphaturic Mesenchymal Tumor, Malignant
- Round Cell Sarcoma
- Well Differentiated Liposarcoma
- Giant Cell Tumor of Soft Parts NOS
- Low Grade Myofibroblastic Sarcoma
- Dermatofibrosarcoma Protuberans, Fibrosarcomatous
Interventions
- PROCEDURE
- RADIATION
- DRUG
No Results Yet